Table 4.
Outcome and causes of mortality of COVID-19 and non-COVID-19 patients.
| Outcome | All (N = 54) |
Cases (N = 30) |
Controls (N = 24) |
p Value |
|---|---|---|---|---|
| Mortality after first CPE infection (30 d) | 13 (24.1) | 9 (30.0) | 4 (16.7) | .255 |
| Final outcome | ||||
| Alive | 33 (61.1) | 17 (56.7) | 16 (66.7) | .437 |
| Dead (CPE infection) | 11 (20.4) | 8 (26.7) | 3 (12.5) | |
| Dead (other causes)a | 10 (18.5) | 5 (16.7) | 5 (20.8) | |
| Mortality (in-hospital) | 21 (38.9) | 13 (43.3) | 8 (33.3) | .454 |
| Time from diagnosis of CPE infection to discharge, median (IQR), days | 16 (5–38) | 25 (11–47) | 7 (0–25) | .007 |
Data are presented as n (%).
COVID-19: coronavirus disease 2019; CPE: carbapenemase-producing Enterobacterales.
a
Death was due to COVID-19 in 4 of the 13 patients with SARS-CoV-2 infection.